Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 89

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Diabetic Foot Ulcers: Appraising Standard of Care and Reviewing New Trends in Management

Aldana, Paola C., Khachemoune, Amor·2020·American Journal of Clinical Dermatology
DOI 10.1007/s40257-019-00495-x
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40257-019-00495-x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 50

  1. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017. https://doi.org/10.1056/nejmra1615439. · DOI · Paper page
  2. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990. https://doi.org/10.2337/diacare.13.5.513. · DOI
  3. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Healing diabetic neuropathic foot ulcers: are we getting better? Diabet Med. 2005. https://doi.org/10.1111/j.1464-5491.2004.01375.x. · DOI · Paper page
  4. American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Suppl 1):S124–38. https://doi.org/10.2337/dc19-S011. · DOI
  5. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999. https://doi.org/10.2337/diacare.22.1.157. · DOI
  6. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care. 1995. https://doi.org/10.2337/diacare.18.10.1376. · DOI
  7. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. · DOI · Paper page
  8. Egan AM, Dinneen SF. In-hospital metabolic regulation in patients with a diabetic foot ulcer: is it worthwhile? Diabetes Metab Res Rev. 2016. https://doi.org/10.1002/dmrr.2741. · DOI
  9. Vas PRJ, Edmonds ME, Papanas N. Nutritional supplementation for diabetic foot ulcers: the big challenge. Int J Low Extrem Wounds. 2017. https://doi.org/10.1177/1534734617740254. · DOI
  10. Razzaghi R, Pourbagheri H, Momen-heravi M, et al. The effects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. J Diabetes Complicat. 2017;31(4):766–72. https://doi.org/10.1016/j.jdiacomp.2016.06.017. · DOI
  11. Afzali H, Jafari Kashi AH, Momen-Heravi M, et al. The effects of magnesium and vitamin E co-supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. Wound Repair Regen. 2019. https://doi.org/10.1111/wrr.12701. · DOI
  12. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003. https://doi.org/10.2337/diacare.26.6.1879. · DOI
  13. Lavery LA, Davis KE, Berriman SJ, et al. WHS guidelines update: diabetic foot ulcer treatment guidelines. Wound Repair Regen. 2016. https://doi.org/10.1111/wrr.12391. · DOI
  14. Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med. 2005. https://doi.org/10.1111/j.1464-5491.2005.01640.x. · DOI
  15. Boulton AJM, Armstrong DG, Kirsner RS, et al. Diagnosis and management of diabetic foot complications. Diabetes. 2018. https://doi.org/10.2337/DB20182-1. · DOI
  16. Lipsky BA, Berendt AR, Cornia PB, et al. Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012. https://doi.org/10.1093/cid/cis460. · DOI
  17. Alexiadou K, Doupis J. Management of diabetic foot ulcers. Diabetes Ther. 2012;3(1):4. · DOI
  18. Margolin L, Gialanella P. Assessment of the antimicrobial properties of maggots. Int Wound J. 2010. https://doi.org/10.1111/j.1742-481X.2010.00234.x. · DOI
  19. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007. https://doi.org/10.1007/s00125-006-0491-1. · DOI · Paper page
  20. Kobayashi N, Hirano K, Yamawaki M, et al. Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2018. https://doi.org/10.1002/ccd.27238. · DOI
  21. Causey MW, Ahmed A, Wu B, et al. Society for vascular surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg. 2016. https://doi.org/10.1016/j.jvs.2016.01.011. · DOI
  22. Franklin C, Stoffels-Weindorf M, Hillen U, Dissemond J. Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients. Int Wound J. 2015. https://doi.org/10.1111/iwj.12159. · DOI
  23. Pimenta R, Roda Â, Freitas JP. Ulcerated necrobiosis lipoidica. Acta Med Port. 2018. https://doi.org/10.20344/amp.10477. · DOI
  24. Wynn M, Freeman S. The efficacy of negative pressure wound therapy for diabetic foot ulcers: a systematised review. J Tissue Viability. 2019. https://doi.org/10.1016/j.jtv.2019.04.001. · DOI
  25. Goggins CA, Khachemoune A. The use of hyperbaric oxygen therapy in the treatment of necrotizing soft tissue infections, compromised grafts and flaps, hidradenitis suppurativa, and pyoderma gangrenosum. Acta Dermatovenerologica Alp Pannonica Adriat. 2019. https://doi.org/10.15570/actaapa.2019.20. · DOI
  26. Huang ET, Mansouri J, Murad MH, et al. A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Undersea Hyperb Med. 2015;42(3):205–47. http://www.ncbi.nlm.nih.gov/pubmed/26152105.
  27. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study. Diabetes Care. 1996. https://doi.org/10.2337/diacare.19.12.1338. · DOI
  28. Fedorko L, Bowen JM, Jones W, et al. Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial. Diabetes Care. 2016. https://doi.org/10.2337/dc15-2001. · DOI
  29. Santema KTB, Stoekenbroek RM, Koelemay MJW, et al. Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care. 2018. https://doi.org/10.2337/dc17-0654. · DOI · Paper page
  30. Ma L, Li P, Shi Z, Hou T, Chen X, Du J. A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ostomy Wound Manag. 2013;59(3):18–24.
  31. Dai C, Shih S, Khachemoune A. Skin substitutes for acute and chronic wound healing: an updated review. J Dermatolog Treat. 2018. https://doi.org/10.1080/09546634.2018.1530443. · DOI · Paper page
  32. Santema TBK, Poyck PPC, Ubbink DT. Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: highlights of a Cochrane systematic review. Wound Repair Regen. 2016. https://doi.org/10.1111/wrr.12434. · DOI
  33. Luck J, Rodi T, Geierlehner A, Mosahebi A. Allogeneic skin substitutes versus human placental membrane products in the management of diabetic foot ulcers: a narrative comparative evaluation of the literature. Int J Low Extrem Wounds. 2019. https://doi.org/10.1177/1534734618818301. · DOI
  34. Martinson M, Martinson N. A comparative analysis of skin substitutes used in the management of diabetic foot ulcers. J Wound Care. 2016. https://doi.org/10.12968/jowc.2016.25.sup10.s8. · DOI
  35. Waymack P, Duff RG, Sabolinski M. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. Burns. 2000. https://doi.org/10.1016/S0305-4179(00)00017-6. · DOI · Paper page
  36. Koob TJ, Lim JJ, Massee M, Zabek N, Denozière G. Properties of dehydrated human amnion/chorion composite grafts: implications for wound repair and soft tissue regeneration. J Biomed Mater Res Part B Appl Biomater. 2014. https://doi.org/10.1002/jbm.b.33141. · DOI
  37. Tettelbach W, Cazzell S, Reyzelman AM, Sigal F, Caporusso JM, Agnew PS. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics. Int Wound J. 2019. https://doi.org/10.1111/iwj.12976. · DOI
  38. Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers. Int Wound J. 2015. https://doi.org/10.1111/iwj.12395. · DOI · Paper page
  39. Tchanque-Fossuo CN, Dahle SE, Lev-Tov H, et al. Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: interim results of a comparative efficacy randomized controlled trial. J Tissue Eng Regen Med. 2019. https://doi.org/10.1002/term.2884. · DOI
  40. Papanas N, Maltezos E. Benefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers. Drug Saf. 2010. https://doi.org/10.2165/11534570-000000000-00000. · DOI
  41. Gilligan AM, Waycaster CR, Motley TA. Cost-effectiveness of becaplermin gel on wound healing of diabetic foot ulcers. Wound Repair Regen. 2015. https://doi.org/10.1111/wrr.12285. · DOI
  42. Hirase T, Ruff E, Surani S, Ratnani I. Topical application of platelet-rich plasma for diabetic foot ulcers: a systematic review. World J Diabetes. 2018. https://doi.org/10.4239/wjd.v9.i10.172. · DOI
  43. Lopes L, Setia O, Aurshina A, et al. Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research. Stem Cell Res Ther. 2018. https://doi.org/10.1186/s13287-018-0938-6. · DOI
  44. Xu SM, Liang T. Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene. Exp Ther Med. 2016. https://doi.org/10.3892/etm.2015.2888. · DOI
  45. Qin HL, Zhu XH, Zhang B, Zhou L, Wang WY. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot. Exp Clin Endocrinol Diabetes. 2016. https://doi.org/10.1055/s-0042-103684. · DOI
  46. Huang Q, Yan P, Xiong H, et al. Extracorporeal shock wave therapy for treating foot ulcers in adults with type 1 and type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Can J Diabetes. 2019. https://doi.org/10.1016/j.jcjd.2019.05.006. · DOI
  47. Snyder R, Galiano R, Mayer P, Rogers LC, Alvarez O. Diabetic foot ulcer treatment with focused shockwave therapy: two multicentre, prospective, controlled, double-blinded, randomised phase III clinical trials. J Wound Care. 2018. https://doi.org/10.12968/jowc.2018.27.12.822. · DOI
  48. Ramadhinara A, Poulas K. Use of wireless microcurrent stimulation for the treatment of diabetes-related wounds: 2 case reports. Adv Skin Wound Care. 2013. https://doi.org/10.1097/01.ASW.0000425942.32993.e9. · DOI
  49. Wirsing PG, Habrom AD, Zehnder TM, Friedli S, Blatti M. Wireless micro current stimulation - an innovative electrical stimulation method for the treatment of patients with leg and diabetic foot ulcers. Int Wound J. 2015. https://doi.org/10.1111/iwj.12204. · DOI
  50. Reyzelman AM, Koelewyn K, Murphy M, et al. Continuous temperature-monitoring socks for home use in patients with diabetes: observational study. J Med Internet Res. 2018. https://doi.org/10.2196/12460. · DOI

Cited by

Metadata

Authors
Aldana, P. C., & Khachemoune, A.
Venue
American Journal of Clinical Dermatology
Publisher
Springer Science and Business Media LLC
Published
2019-12-17
Volume
21
Issue
2
Pages
255-264
ISSN
  • 1175-0561
  • 1179-1888
DOI
10.1007/s40257-019-00495-x
Cited by
89
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.